Susquehanna upgraded shares of Lam Research (NASDAQ:LRCX – Free Report) from a neutral rating to a positive rating in a report issued on Thursday, Marketbeat.com reports. The firm currently has $125.00 price objective on the semiconductor company’s stock, up from their previous price objective of $75.00.
Other analysts have also recently issued reports about the stock. Barclays decreased their price target on shares of Lam Research from $90.00 to $75.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. Mizuho decreased their target price on shares of Lam Research from $95.00 to $90.00 and set an “outperform” rating for the company in a research note on Friday, January 10th. B. Riley dropped their price target on shares of Lam Research from $132.50 to $105.00 and set a “buy” rating on the stock in a research note on Wednesday, October 23rd. Stifel Nicolaus reissued a “buy” rating and set a $100.00 price objective (down previously from $105.00) on shares of Lam Research in a research report on Thursday, October 24th. Finally, Wells Fargo & Company upped their target price on Lam Research from $82.00 to $85.00 and gave the stock an “equal weight” rating in a research report on Thursday, January 30th. Six equities research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company. Based on data from MarketBeat.com, Lam Research currently has a consensus rating of “Moderate Buy” and a consensus price target of $98.22.
Check Out Our Latest Stock Report on LRCX
Lam Research Price Performance
Lam Research (NASDAQ:LRCX – Get Free Report) last posted its quarterly earnings results on Wednesday, January 29th. The semiconductor company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.87 by $0.04. Lam Research had a return on equity of 51.86% and a net margin of 26.49%. Equities analysts expect that Lam Research will post 3.71 earnings per share for the current fiscal year.
Lam Research Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 9th. Investors of record on Wednesday, March 5th will be issued a dividend of $0.23 per share. This represents a $0.92 annualized dividend and a dividend yield of 1.03%. The ex-dividend date of this dividend is Wednesday, March 5th. Lam Research’s dividend payout ratio is currently 27.95%.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of LRCX. Migdal Insurance & Financial Holdings Ltd. boosted its holdings in Lam Research by 2,400.0% during the third quarter. Migdal Insurance & Financial Holdings Ltd. now owns 200 shares of the semiconductor company’s stock valued at $163,000 after acquiring an additional 192 shares during the period. Insight Wealth Partners LLC acquired a new position in shares of Lam Research during the 3rd quarter worth about $202,000. B&L Asset Management LLC bought a new stake in Lam Research during the 3rd quarter valued at approximately $204,000. CWC Advisors LLC. acquired a new stake in Lam Research in the 3rd quarter valued at approximately $220,000. Finally, Dynamic Technology Lab Private Ltd bought a new position in Lam Research in the 3rd quarter worth approximately $220,000. 84.61% of the stock is currently owned by institutional investors and hedge funds.
About Lam Research
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Further Reading
- Five stocks we like better than Lam Research
- How Can Investors Benefit From After-Hours Trading
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- 5 Top Rated Dividend Stocks to Consider
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- 3 Healthcare Dividend Stocks to Buy
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.